Skip to content
中文产业新闻精选评分76Chinese source

依康坦博妥塔单抗TAISHAN-302 III期数据WCLC全体大会首发并同步发表NEJM

2026 WCLC | 重磅首发并同步登顶NEJM！张力教授全体大会公布TAISHAN-302研究：依康坦博妥塔单抗重塑复发性SCLC治疗新格局

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.